Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

NCT01619046 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

BIOLOGICAL: GreenGene™ F and an approved recombinant Factor VIII product
BIOLOGICAL: GreenGene™ F
BIOLOGICAL: GreenGene™ F
BIOLOGICAL: GreenGene™ F

Sponsor

Green Cross Corporation

Collaborators

[object Object]